Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof

A synthesis method and technology of isoindoline are applied in the directions of drug combination, organic chemistry, antitumor drugs, etc., to achieve the effects of simple post-processing and improved yield

Active Publication Date: 2013-08-28
SHANGHAI SYNTHEALL PHARM CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The object of the present invention is to provide an important drug molecule 2-methyl-7-(5-chloro-2-arylaminopyrimidine-4-amino)- A novel synthetic method for 4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)isoindoline-1-one, which mainly solves the problem that the single-line synthetic route of the existing synthetic method is too long and exists Technical problems such as difficult separation and purification, low yield, high synthesis cost, and limited applicability

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof
  • Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof
  • Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020]

[0021] 1.2, the synthetic technique of 5-dichloro-4-methylthiopyrimidine 2

[0022] 2,4,5-Trichloropyrimidine 1 (80g, 0.44mol) was dissolved in tetrahydrofuran (1000mL), and then a 21% by weight aqueous sodium methylthiolate solution (150g, 0.45mol) was slowly added dropwise to the reaction in the liquid. After the dropwise addition was completed, the reaction solution was stirred at room temperature for 24 hours. The reaction solution was poured into 200 mL of water. The mixture was extracted three times with 1 L of ethyl acetate. The combined organic phases were dried over anhydrous sodium sulfate. The desiccant was filtered, and the filtrate was concentrated to dryness to obtain 80g of pure product 2,5-dichloro-4-methylthiopyrimidine 2 (yield: 93%)

[0023] H NMR spectrum 1 H-NMR (DMSO, 400MHz): δ8.19 (s, 1H), 2.58 (s, 3H); MS (ESI) m / e (M+H + )195.

[0024] 2.2, The synthetic technique of 5-dichloro-4-methylthiopyrimidine 2

[0025] 2,4,5-Trichloropyrim...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an synthesizing method of 2-methyl-7-( substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and an intermediate thereof, mainly solving the technical problems of overlength single-line synthetic route, difficult separation and purification, low productivity, high synthesizing cost, narrow applicability, and the like of the traditional synthesizing method. The process method comprises the following steps of: carrying out substitution reaction on 2,4,5-trichloropyrimidine as a raw material and sodium methyl mercaptideto generate the intermediate, i.e. 2,5-dichloro-4-methylthiopyrimidine; then carrying out the substitution reaction with aromatic amine to generate the intermediate, i.e. 2-aromatic amino-4-methylthio-5-chloropyrimidine; then hydrolyzing the methylthio to generate the intermediate, i.e. 2-aromatic amino-4-hydroxy-5-chloropyrimidine; enabling a hydroxyl compound to generate dichloride under the action of phosphorus oxychloride; and finally carrying out the substitution reaction with amine to obtain the 2-methyl-7-(5-chlorine-2-aromatic amido-pyrimidine-4-amino)-4-(4-(4-methyl piperazine-1-base) piperidine-1-base) isoindoline-1-ketone under the action of hydrogen chloride ethyl acetate.

Description

Technical field: [0001] The invention relates to a synthetic method of a class of important drug molecule 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperidin-1-yl)isoindoline-1-one and intermediates, That is, 2-methyl-7-(5-chloro-2-arylaminopyrimidine-4-amino)-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)iso Synthesis method of indolin-1-one and intermediate 2-arylamino-4,5-dichloropyrimidine. Background technique: [0002] 2-Methyl-7-(5-chloro-2-arylaminopyrimidine-4-amino)-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)isoind Indolin-1-ones are an important class of drug molecules, as inhibitors of focal adhesion kinase (FAK), they can be used as drugs to treat the dysfunction of signal cascades related to focal adhesion kinase. ) and thus have antitumor biological activity. Currently there is only one PCT patent application (WO 2006 / 021457) reporting the synthetic route of related compounds. However, we found in the course of the experiment that compound...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/14C07D239/42A61P35/00
Inventor 张培权肖贻崧范辉胜廖江鹏贺海鹰陈曙辉
Owner SHANGHAI SYNTHEALL PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products